Eva-Maria Schmelz

1.4k total citations
7 papers, 1.1k citations indexed

About

Eva-Maria Schmelz is a scholar working on Molecular Biology, Cell Biology and Biochemistry. According to data from OpenAlex, Eva-Maria Schmelz has authored 7 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Biochemistry. Recurrent topics in Eva-Maria Schmelz's work include Sphingolipid Metabolism and Signaling (4 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Caveolin-1 and cellular processes (2 papers). Eva-Maria Schmelz is often cited by papers focused on Sphingolipid Metabolism and Signaling (4 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Caveolin-1 and cellular processes (2 papers). Eva-Maria Schmelz collaborates with scholars based in United States and Germany. Eva-Maria Schmelz's co-authors include Alfred H. Merrill, Dirck L. Dillehay, Hubert W. Vesper, Daniel V. Lynch, Mariana Nikolova‐Karakashian, Filmore I. Meredith, Elaine Wang, Ronald T. Riley, Paul C. Roberts and M. Cameron Sullards and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Nutrition and PubMed.

In The Last Decade

Eva-Maria Schmelz

7 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva-Maria Schmelz United States 7 732 192 172 158 143 7 1.1k
Corinna Herz Germany 22 642 0.9× 215 1.1× 117 0.7× 72 0.5× 209 1.5× 46 1.1k
Adriano Pinetti Italy 13 347 0.5× 106 0.6× 54 0.3× 100 0.6× 129 0.9× 33 1.1k
Jeong Won Yun South Korea 16 827 1.1× 97 0.5× 89 0.5× 54 0.3× 140 1.0× 22 1.1k
Yan Gu United States 17 521 0.7× 52 0.3× 157 0.9× 51 0.3× 226 1.6× 23 1.2k
D J Judah United Kingdom 25 1.1k 1.6× 207 1.1× 129 0.8× 89 0.6× 738 5.2× 50 2.1k
R. Keith Randolph United States 19 433 0.6× 104 0.5× 113 0.7× 57 0.4× 68 0.5× 28 846
Keishi Hata Japan 18 556 0.8× 58 0.3× 79 0.5× 61 0.4× 114 0.8× 62 1.1k
G. E. Milo United States 16 402 0.5× 54 0.3× 193 1.1× 84 0.5× 141 1.0× 35 956
Do Youn Jun South Korea 19 600 0.8× 103 0.5× 39 0.2× 43 0.3× 116 0.8× 58 1.0k
Myoung‐Sool Do South Korea 17 291 0.4× 64 0.3× 116 0.7× 136 0.9× 129 0.9× 35 856

Countries citing papers authored by Eva-Maria Schmelz

Since Specialization
Citations

This map shows the geographic impact of Eva-Maria Schmelz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva-Maria Schmelz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva-Maria Schmelz more than expected).

Fields of papers citing papers by Eva-Maria Schmelz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva-Maria Schmelz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva-Maria Schmelz. The network helps show where Eva-Maria Schmelz may publish in the future.

Co-authorship network of co-authors of Eva-Maria Schmelz

This figure shows the co-authorship network connecting the top 25 collaborators of Eva-Maria Schmelz. A scholar is included among the top collaborators of Eva-Maria Schmelz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva-Maria Schmelz. Eva-Maria Schmelz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Schmelz, Eva-Maria, Paul C. Roberts, Lori Lemonnier, et al.. (2001). Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.. PubMed. 61(18). 6723–9. 108 indexed citations
2.
Grégoire, Lucie, Raja Rabah, Eva-Maria Schmelz, et al.. (2001). Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro.. PubMed. 7(12). 4280–7. 38 indexed citations
3.
Vesper, Hubert W., Eva-Maria Schmelz, Mariana Nikolova‐Karakashian, et al.. (1999). Sphingolipids in Food and the Emerging Importance of Sphingolipids to Nutrition. Journal of Nutrition. 129(7). 1239–1250. 449 indexed citations
4.
Humpf, Hans‐Ulrich, Eva-Maria Schmelz, Filmore I. Meredith, et al.. (1998). Acylation of Naturally Occurring and Synthetic 1-Deoxysphinganines by Ceramide Synthase. Journal of Biological Chemistry. 273(30). 19060–19064. 129 indexed citations
5.
Merrill, Alfred H., Eva-Maria Schmelz, E Wang, et al.. (1997). Importance of Sphingolipids and Inhibitors of Sphingolipid Metabolism as Components of Animal Diets. Journal of Nutrition. 127(5). 830S–833S. 68 indexed citations
6.
Merrill, Alfred H., Eva-Maria Schmelz, Elaine Wang, et al.. (1995). Role of Dietary Sphingolipids and Inhibitors of Sphingolipid Metabolism in Cancer and Other Diseases. Journal of Nutrition. 125(6 Suppl). 1677S–1682S. 53 indexed citations
7.
Dillehay, Dirck L., et al.. (1994). Dietary Sphingomyelin Inhibits 1,2-Dimethylhydrazine–Induced Colon Cancer in CF1 Mice. Journal of Nutrition. 124(5). 615–620. 215 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026